Jianyuan Wu

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

Chang Chen, Yi Zhang, Jianying Huang et al. · medRxiv · 2020 · 794 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Shipo Wu, Jianying Huang, Zhe Zhang et al. · The Lancet Infectious Diseases · 2021 · 300 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial

Chang Chen, Yi Zhang, Jianying Huang et al. · Frontiers in Pharmacology · 2021 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study

Ying Feng, Jianying Huang, Jianyuan Wu et al. · Cell Proliferation · 2020 · 92 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem

Yanjun Zhong, Guicheng Dong, Haiguang Luo et al. · Toxicology · 2012 · 74 citations

Pharmacy, Pharmacology, Toxicology +15